Antiplatelet has been the cornerstones management of acute coronary syndrome. However, numbers of patients on these agents had episodes of adverse cardiovascular events. A 65-year-old woman post cardiac coronary bypass surgery on dual antiplatelet therapy, Aspirin, and Clopidogrel underwent several episodes of thrombotic events despite good adhered to thedailyantiplatelet regimen.These recurrent events had led to clinical suspicious of antiplatelet resistance. Platelet function test was performed which indicates a poor platelet response to Clopidogrel. Clopidogrelwas discontinued and Ticagrelor was prescribed together with Aspirin. During two months of follow up, there is no episode of chest discomfort.
|Journal||IOP Conference Series: Earth and Environmental Science|
|Publication status||Published - 26 Mar 2018|
|Event||1st International Conference on Tropical Medicine and Infectious Diseases, ICTROMI 2017, in conjunction with The 23rd National Congress of the Indonesian Society of Tropical and Infectious Diseases Consultant, ISTIC 2017 and the 18th Annual Meeting of Internal Medicine Department, Faculty of Medicine, Universitas Sumatera - Medan, Indonesia|
Duration: 15 Nov 2017 → 18 Nov 2017